Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ACHC · against 350 other Healthcare companies of similar size
Ranked #170 of 351 · scores higher than 51% of peers
Bars: peers in each 10-point band of the valuation score35 peers with a valuation score of 50–59, including ACHC · Click a bar to see the companies
A mix: stronger EBITDA yield, but weaker earnings yield and free cash flow yield than most Healthcare peers.
| Metric | ACHC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 343 reported | -41.9% | 2.3% | 1% | 30% | |
| EBITDA yieldHigher is better · 348 reported | 9.9% | 4.7% | 80% | 50% | |
| Free cash flow yieldHigher is better · 179 reported | -4.9% | 0.2% | 30% | 20% | |
| Book yieldHigher is better · 343 reported | 73.5% | 32.1% | 87% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 165 | 24.7B CNY (≈$3.5B) | 58 | 39 | |
| 165 | 22.0B SEK (≈$2.2B) | 58 | 51 | |
| 165 | 2.2B USD | 58 | 61 | |
| 170 | 5.24T KRW (≈$3.8B) | 57 | 60 | |
| 170 | 2.8B USD | 57 | 33 | |
| 170 | 1.8B USD | 57 | 52 | |
| 170 | 2.9B USD | 57 | 50 | |
| 170 | 41.9B SEK (≈$4.2B) | 57 | 53 | |
| 175 | 3.0B USD | 56 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score